One year after becoming available for older Americans and pregnant women, receptive public opinion of respiratory syncytial ...

Respiratory syncytial virus (RSV) is on the rise in Indiana, according to the Centers for Disease Control and Prevention, and ...

Covering coughs and sneezes and washing your hands can help prevent infections, according to the New York City health ...

Respiratory syncytial virus, or RSV, is a common respiratory virus that infects the nose, throat, and lungs. According to the ...

All participants had respiratory swabs collected and tested for RSV. Though previous trials have shown high VE, most trialed ...

The Ministry of Public Health (MoPH), in collaboration with Hamad Medical Corp (HMC) and Primary Health Care Corp (PHCC), is ...

Respiratory viruses typically experience their highest levels in the wintertime, and this year will likely be no different.

But enrollment for all clinical studies of infant RSV vaccines is now on hold due to safety concerns, explained a Dec. 11 ...

Respiratory Syncytial Virus Prefusion F (RSVpreF) vaccination is effective against RSV-related lower respiratory tract ...

Respiratory syncytial virus (RSV) is a major cause of respiratory infections, particularly in infants, children under 5 years, and older adults. Its rapid spread makes RSV a serious public health ...

RSV prevention among children, including nirsevimab and the maternal RSVpreF vaccine, may be associated with a reduction in pediatric ICU utilization.

An FDA approval of Merck’s drug clesrovimab by June would give physicians another option for protecting newborns from ...